{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:27:47Z","timestamp":1758054467656,"version":"3.44.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Despite the ongoing rise in the global burden of non-alcoholic steatohepatitis-related liver cancer (NALC), systematic analyses and long-term trend projections of the disease\u2019s burden in the BRICS countries (Brazil, Russia Federation, India, China, and South Africa) remain relatively scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this study was to systematically assess the incidence dynamics of NALC in the BRICS countries during the period from 1990 to 2021 to reveal its epidemiological characteristics, to assess the potential public health challenges, and to forecast the development trends over the next 15 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present study collated and systematized the incidence data of NALC in the BRICS countries from 1990 to 2021, drawing upon the global burden of disease database (2021). The indicators that were analyzed included the incidence rate, the age-standardized incidence rate, the annual percentage change, and the average annual percentage change. The analysis incorporated the utilization of two distinct models: the joinpoint regression model and the age\u2013period\u2013cohort model. These models were employed to evaluate the temporal effects and population characteristics. Additionally, the autoregressive integrated moving average model was implemented to offer insights into the potential future risk of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 1990 to 2021, the incidence of NALC in the BRICS countries demonstrated a marked increase. The incidence rate in China exhibited an increase from 0.34 (95% uncertainty interval (UI): 0.28\u20130.42) to 0.79 (95% UI: 0.61\u20131.01). Brazil demonstrated a rise from 0.07 (95% UI: 0.06\u20130.08) to 0.17 (95% UI: 0.15\u20130.20). The Russian Federation demonstrated a rise from 0.14 (95% UI: 0.12\u20130.16) to 0.39 (95% UI: 0.33\u20130.45). India demonstrated a rise from 0.13 (95% UI: 0.10\u20130.16) to 0.32 (95% UI: 0.26\u20130.38). South Africa demonstrated a rise from 0.29 (95% UI: 0.18\u20130.47) to 0.74 (95% UI: 0.59\u20130.89). The sex analysis demonstrated that, in the majority of countries except India, the male incidence rate exhibited a higher rate of increase than the female incidence rate. The steepest age-specific increase occurred in the oldest cohorts, notably 90+ years. The predictions derived from the autoregressive integrated moving average model indicate that the prevalence of NALC morbidity is anticipated to escalate in the BRICS nations over the ensuing 15-year period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The present study reveals a sustained upward trend in NALC incidence in the BRICS countries during 1990\u20132021 and significant differences in the pace and drivers of growth across countries. The heterogeneity reflected by the joinpoint and APC models reveals gaps in the burden of metabolic diseases, public health response, and policy implementation across countries. In order to address this challenge, priority should be given to the promotion of metabolic disease-related early screening, health behavior interventions, and systematic management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1632843","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:12:34Z","timestamp":1757909554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparison of trends in the incidence of non-alcoholic steatohepatitis-related liver cancer in the BRICS countries from 1990 to 2021, alongside projections for the next 15 years"],"prefix":"10.3389","volume":"15","author":[{"given":"Congjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatol Baltim Md"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"B3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cancers15010023","article-title":"Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies","volume":"15","author":"Guti\u00e9rrez-Cuevas","year":"2022","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41256-023-00318-x","article-title":"The priority areas and possible pathways for health cooperation in BRICS countries","volume":"8","author":"Liu","year":"2023","journal-title":"Glob Health Res Policy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60075-1","article-title":"An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS)","volume":"384","author":"Marten","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1467385","article-title":"Time trends in anxiety disorders incidence across the BRICS: an age\u2013period\u2013cohort analysis for the GBD 2021","volume":"12","author":"Liu","year":"2024","journal-title":"Front Public Health"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","article-title":"Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B9","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B10","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13098-022-00976-w","article-title":"Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-025-03135-7","article-title":"Long-term trends in the burden of asthma in China: a joinpoint regression and age\u2013period\u2013cohort analysis based on the GBD 2021","volume":"26","author":"Li","year":"2025","journal-title":"Respir Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12889-025-21310-9","article-title":"Epidemiological trends and age\u2013period\u2013cohort effects on ischemic stroke burden across the BRICS-plus from 1992 to 2021","volume":"25","author":"Cheng","year":"2025","journal-title":"BMC Public Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1038\/s41598-025-96175-4","article-title":"Comparative diabetes mellitus burden trends across global, Chinese, US, and Indian populations using GBD 2021 database","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"B16","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.825541","article-title":"Trends in the incidence and DALYs of urolithiasis from 1990 to 2019: results from the global burden of disease study 2019","volume":"10","author":"Li","year":"2022","journal-title":"Front Public Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/03014460.2019.1707872","article-title":"Age period cohort analysis: a review of what we should and shouldn\u2019t do","volume":"47","author":"Bell","year":"2020","journal-title":"Ann Hum Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12884-024-06931-z","article-title":"Time trends in maternal hypertensive disorder incidence in Brazil, Russian Federation, India, China, and South Africa (BRICS): an age\u2013period\u2013cohort analysis for the GBD 2021","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0962280218801121","article-title":"A new age\u2013period\u2013cohort model for cancer surveillance research","volume":"28","author":"Rosenberg","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1425043","article-title":"Comparison of secular trends of leukemia in China and the United States from 1990 to 2021 and their projections for the next 15 years","volume":"12","author":"Ge","year":"2024","journal-title":"Front Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2764","article-title":"Age\u2013period\u2013cohort models for the Lexis diagram","volume":"26","author":"Carstensen","year":"2007","journal-title":"Stat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age\u2013period\u2013cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100122","article-title":"The disease burden, risk factors and future predictions of Alzheimer\u2019s disease and other types of dementia in Asia from 1990 to 2021","volume":"12","author":"Guo","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.3390\/ijerph17155294","article-title":"Are the chinese moving toward a healthy diet? Evidence from macro data from 1961 to 2017","volume":"17","author":"Han","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1038\/s41598-022-14701-0","article-title":"Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2458-12-210","article-title":"Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors","volume":"12","author":"Danquah","year":"2012","journal-title":"BMC Public Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60055-X","article-title":"Health conditions and health-policy innovations in Brazil: the way forward","volume":"377","author":"Victora","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000829","article-title":"The Brazilian health system at crossroads: progress, crisis and resilience","volume":"3","author":"Massuda","year":"2018","journal-title":"BMJ Glob Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"B34","article-title":"Nations within a nation: variations in epidemiological transition across the states of India, 1990\u20132016 in the Global Burden of Disease Study","volume":"390","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.02.010","article-title":"Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study)","volume":"115","author":"Dedov","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-9276-11-31","article-title":"Differences in health care seeking behaviour between rural and urban communities in South Africa","volume":"11","author":"van der Hoeven","year":"2012","journal-title":"Int J Equity Health"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02040-4","article-title":"Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990-2019: a decomposition and age\u2013period\u2013cohort analysis","volume":"58","author":"Liu","year":"2023","journal-title":"J Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","article-title":"Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells","volume":"25","author":"Mu","year":"2024","journal-title":"Curr Genomics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40249-024-01225-0","article-title":"Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review","volume":"13","author":"Li","year":"2024","journal-title":"Infect Dis Poverty"},{"key":"B41","doi-asserted-by":"publisher","first-page":"bqaa134","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"B43","unstructured":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease\n          \n          \n          2025"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatol Baltim Md"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1038\/jp.2016.184","article-title":"Health systems in India","volume":"36","author":"Chokshi","year":"2016","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10053","article-title":"Molecular and biological hallmarks of ageing","volume":"103","author":"Aunan","year":"2016","journal-title":"Br J Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.891963","article-title":"Worldwide long-term trends in the incidence of nonalcoholic fatty liver disease during 1990-2019: A joinpoint and age\u2013period\u2013cohort analysis","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","volume":"20","author":"Younossi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-devpsych-121318-084950","article-title":"Childhood adversity and neural development: A systematic review","volume":"1","author":"McLaughlin","year":"2019","journal-title":"Annu Rev Dev Psychol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-025-10782-x","article-title":"Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990-2021: a multi-model trend analysis and forecasting study","volume":"19","author":"Yang","year":"2025","journal-title":"Hepatol Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr Genomics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem Biol Interact"},{"key":"B57","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"B58","unstructured":"Health system outcomes in BRICS countries and their association with the economic context\n          \n          \n          2025"},{"key":"B59","unstructured":"Social inequalities and the early provision and dispersal of COVID-19 vaccinations in the United States: A population trends study\n          \n          37460352\n          \n          2025"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429310703240823045808","article-title":"Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation","volume":"17","author":"Sensi","year":"2024","journal-title":"Curr Mol Pharmacol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1632843\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:12:36Z","timestamp":1757909556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1632843\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":60,"alternative-id":["10.3389\/fonc.2025.1632843"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1632843","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1632843"}}